Development of an integrative model of coping. A prospective longitudinal study of patients with oral cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006263

Enrollment

200

Registered

2014-06-30

Start date

2014-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C44

Interventions

Group 1: Patients with squamous cell carcinoma are examined before operation (T1), directly after operation (T2), 3 (T3) and 6 months (T4) later in terms of their personality, social support, coping,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: squamous majority Written informed consent

Exclusion criteria

Exclusion criteria: Tumor recurrence precancer Inability to follow-up survey Pregnancy or breastfeeding Heart, lung, liver or kidney disease Chronic Pain drug addiction recent surgery infections Circulatory disorders Systemic diseases Allergic reaction to drugs

Design outcomes

Primary

Measure	Time frame
Patients will be asked before the diagnosis of cancer (T1) with the following Questionnaires as a paper-pencil version (total duration about 50 - 60 min): Brief Symptom Check List (BSCL 53; Franke, in prep.); Freiburg Personality Inventory (FPI-R; mountain driving, jumping, & Selg, 2010); Questionnaire on social support (F-SozU; Fydrich, Summer, & Brähler, 2007); Commitment to spiritual and religious practices (SpREUK-P SF 17; Bussing, Reiser, Michalsen, & Baumann, 2012) Questionnaire on competence and control beliefs (FKK; Staple, 1991) Herth Hope Index (HHIndex; Herth, 1992); Life Orientation Test Revision (LOT-R; Glaesmer, Hoyer, Klotsche, & Herzberg, 2008); Positive and negative religious coping (Brief COPE, teaching, Fehlberg, Hess, & Fix, 2007) Scales for the Assessment of hopelessness (H-scales; Staple, 1994); State-Trait Anger Expression Inventory (STAXI; Schwenkmezger, Hodapp, & Spielberger, 1992); University of Washington Quality of Life Scale (UW-QOL 4; Lowe & Rogers, 1999). Ways of Coping Cancer Version (WOC-CA; (dark-Schetter, Feinstein, Taylor, & Falke, 1992). The second survey takes place directly after surgical treatment (T2). There the coping, quality of life and symptom severity are surveyd (approximately 30 - 40 min.). In addition, existing blood analysis ??from the medical treatment by the hospital are involved (in immune status analysis). The initial tumor size is determined in the presence of imaging techniques. After about 3 (T3) and 6 months (T4) again coping, quality of life, symptom severity and religious coping is surveyd (duration approximately 30 minutes) and the values ??of the blood analyzes and the rate of tumor growth are analyzed (in the presence of radiological examinations).	—

Measure

Time frame

Patients will be asked before the diagnosis of cancer (T1) with the following Questionnaires as a paper-pencil version (total duration about 50 - 60 min): Brief Symptom Check List (BSCL 53; Franke, in prep.); Freiburg Personality Inventory (FPI-R; mountain driving, jumping, & Selg, 2010); Questionnaire on social support (F-SozU; Fydrich, Summer, & Brähler, 2007); Commitment to spiritual and religious practices (SpREUK-P SF 17; Bussing, Reiser, Michalsen, & Baumann, 2012) Questionnaire on competence and control beliefs (FKK; Staple, 1991) Herth Hope Index (HHIndex; Herth, 1992); Life Orientation Test Revision (LOT-R; Glaesmer, Hoyer, Klotsche, & Herzberg, 2008); Positive and negative religious coping (Brief COPE, teaching, Fehlberg, Hess, & Fix, 2007) Scales for the Assessment of hopelessness (H-scales; Staple, 1994); State-Trait Anger Expression Inventory (STAXI; Schwenkmezger, Hodapp, & Spielberger, 1992); University of Washington Quality of Life Scale (UW-QOL 4; Lowe & Rogers, 1999). Ways of Coping Cancer Version (WOC-CA; (dark-Schetter, Feinstein, Taylor, & Falke, 1992). The second survey takes place directly after surgical treatment (T2). There the coping, quality of life and symptom severity are surveyd (approximately 30 - 40 min.). In addition, existing blood analysis ??from the medical treatment by the hospital are involved (in immune status analysis). The initial tumor size is determined in the presence of imaging techniques. After about 3 (T3) and 6 months (T4) again coping, quality of life, symptom severity and religious coping is surveyd (duration approximately 30 minutes) and the values ??of the blood analyzes and the rate of tumor growth are analyzed (in the presence of radiological examinations).

—

Countries

Germany

Contacts

Public ContactMadiha Rana

Helmut-Schmidt-Universität Universität der Bundeswehr Hamburg

rana@hsu-hh.de040-6541-2932

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026